HEM

SAKK/BMS Grant «HEM Pioneer»

Many types of blood cancer remain incurable and are associated with severe morbidity and increased mortality. SAKK’s HEM Pioneer Grant is funded by BMS and aims to support projects and research that could potentially pave the way for a game changing outcome in the field of blood cancers. The Grant is endowed with CHF 50,000.

The call for proposal is open now. Your application must be submitted electronically via our webpage.  Please send your application until September 30, 2021.

For further details please read the rules and regulations on our website.

 

  • Application «HEM Pioneer»

    Salutation
    Is the project conducted in Switzerland?
    Is this proposal part of a larger research project/trial?
    One file only.
    200 MB limit.
    Allowed types: pdf.
    One file only.
    200 MB limit.
    Allowed types: pdf.
    Unlimited number of files can be uploaded to this field.
    50 MB limit.
    Allowed types: pdf.
    Unlimited number of files can be uploaded to this field.
    50 MB limit.
    Allowed types: pdf.

  • Flyer «HEM Pioneer»

  • SAKK Coordinating Center
    Tanja Brauen
    Effingerstrasse 33
    CH-3008 Bern
    Tel: +41 31 389 91 91
    E-Mail: events@sakk.ch

  • Rules and Regulation «HEM Pioneer»

  • HEM

    Der SAKK/Celgene Grant 2020 ging an Dr. med. Mattia Rizzi vom Waadtländer Universitätsspital (CHUV) für das Projekt «Prediction of thrombohemorragic complications in children with acute lymphoblastic leukemia and lymphoblastic lymphoma: the role of novel global hemostasis assays».

     

    Press Release SAKK / Celgene “HEM Pioneer Grant” 2019

    HEMProf. Dr. med. Gabriela Baerlocher (Jury President and SAKK Board Member) with Dr. med. Corinne Widmer (University Hospital Zurich)